Nebraska Cancer Research Center is a clinical research site located in Lincoln, Nebraska, United States 68510.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Nebraska Cancer Research Center has participated in 92 clinical trials with 36 currently active.
Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Cancer Research Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Cancer Research Center has 92 clinical trials on record, with 36 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.
Nebraska Cancer Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.